Related references
Note: Only part of the references are listed.Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes
O. Landgren et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma
BaoHan T. Vo et al.
CELL REPORTS (2017)
Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1
Diana G. Wright et al.
ONCOTARGET (2016)
Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease
Jing Fu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
Tarik Moeroey et al.
BLOOD (2015)
Pathogenesis beyond the cancer clone(s) in multiple myeloma
Giada Bianchi et al.
BLOOD (2015)
p53 haploinsufficiency and functional abnormalities in multiple myeloma
P. J. Teoh et al.
LEUKEMIA (2014)
Growth Factor Independence 1 Antagonizes a p53-Induced DNA Damage Response Pathway in Lymphoblastic Leukemia
Cyrus Khandanpour et al.
CANCER CELL (2013)
GFI1 Is Repressed by p53 and Inhibits DNA Damage-Induced Apoptosis
Pei Du et al.
PLOS ONE (2013)
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S. K. Kumar et al.
LEUKEMIA (2012)
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1
A. R. Soliera et al.
LEUKEMIA (2012)
Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
Sonia D'Souza et al.
BLOOD (2011)
The Clinical Impact and Molecular Biology of del(17p) in Multiple Myeloma Treated with Conventional or Thalidomide-Based Therapy
Kevin D. Boyd et al.
GENES CHROMOSOMES & CANCER (2011)
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
W-J Chng et al.
LEUKEMIA (2011)
Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation
Tarik Moroy et al.
SEMINARS IN IMMUNOLOGY (2011)
The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity
Clinton J. V. Campbell et al.
BLOOD (2010)
Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting
Jana Cumova et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype
Noriyoshi Kurihara et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Adhesive Interactions Regulate Transcriptional Diversity in Malignant B Cells
Liat Nadav-Dagan et al.
MOLECULAR CANCER RESEARCH (2010)
Gfi1 and Gfi1b: key regulators of hematopoiesis
L. T. van der Meer et al.
LEUKEMIA (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
β1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
Kenneth H. Shain et al.
CANCER RESEARCH (2009)
Specific activation of the p53 pathway by low dose actinomycin D A new route to p53 based cyclotherapy
Meng Ling Choong et al.
CELL CYCLE (2009)
p53 Regulates Hematopoietic Stem Cell Quiescence
Yan Liu et al.
CELL STEM CELL (2009)
Tumor Suppressive Functions of p53
Jack T. Zilfou et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1
Shireen Saleque et al.
MOLECULAR CELL (2007)
Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression
Y. Nakazawa et al.
ONCOGENE (2007)
Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes
Jurgen A. F. Marteijn et al.
BLOOD (2007)
The growth factor independence-1 transcription factor: New functions and new insights
Avedis Kazanjian et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Increased CCAAT enhancer-binding protein ε(C/EBPε) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia
DZ Zhuang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1
ZJ Duan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/senseless proteins
H Tsuda et al.
CELL (2005)
Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells
JT Opferman et al.
SCIENCE (2005)
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength
CA O'Brien et al.
ENDOCRINOLOGY (2004)
Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells
A Kazanjian et al.
CANCER RESEARCH (2004)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
Targets of the transcriptional repressor oncoprotein Gfi-1
ZJ Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation
JF Zhu et al.
IMMUNITY (2002)
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3
B Rödel et al.
EMBO JOURNAL (2000)
Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-alpha
R Minami et al.
EXPERIMENTAL HEMATOLOGY (2000)
Share Paper
